Skip to main content
Clinical Trials/JPRN-jRCT1042220099
JPRN-jRCT1042220099
Recruiting
未知

Randomized Trial Comparing Franseen Needle Versus Trident Needle and Three-Point Needle in EUS-FNB for Solid Pancreatic Lesions - Fantathtic Study

Ishikawa Takuya0 sites192 target enrollmentNovember 25, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Solid pancreatic lesions not less than 10 mm
Sponsor
Ishikawa Takuya
Enrollment
192
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 25, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Ishikawa Takuya

Eligibility Criteria

Inclusion Criteria

  • (1\)Patients with solid pancreatic lesions not less than 10 mm on CT or MRI which require histological diagnosis by EUS\-FNB.
  • (2\)Patients over 20 years old at the time of enrollment.
  • (3\)Preservation of bone marrow function at the time of diagnosis.
  • (4\)Patients in which antithrombotic drugs are not used within one week or can be withdrawn or replaced.
  • (5\)Provision of written consent to participate in the study.

Exclusion Criteria

  • (1\)Uncontrollable infection including active tuberculosis
  • (2\)Serious adverse events
  • (3\)Severe mental disorder
  • (4\)Judgement as being ineligible by the principal or subinvestigator.

Outcomes

Primary Outcomes

Not specified

Similar Trials